Evidence map›Paper›PMID 31882898›Full record

ArticleScientific reports2019

A natural polymorphism in Zika virus NS2A protein responsible of virulence in mice.

Gines Ávila-Pérez, Aitor Nogales, Jun-Gyu Park, Silvia Márquez-Jurado, Francisco J Iborra, Fernando Almazan, Luis Martínez-Sobrido

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Reverse Genetics of Zika Virus Using a Bacterial Artificial Chromosome.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  6. African ZIKV lineage fails to sustain infectivity in an in vitro mimetic urban cycle.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Zika Virus Infection of PregnantJournal of virology · 2021
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Placental Myeloid Cells Protect against Zika Virus Vertical Transmission in aJournal of immunology (Baltimore, Md. : 1950) · 2020
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 3 countries.

Gines Ávila-PérezDepartment of Microbiology and Immunology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, New York, 14642, USA.
Aitor NogalesDepartment of Microbiology and Immunology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, New York, 14642, USA.
Jun-Gyu ParkDepartment of Microbiology and Immunology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, New York, 14642, USA.
Silvia Márquez-JuradoDepartment of Molecular and Cell Biology, Centro Nacional de Biotecnología (CNB-CSIC), Universidad Autonóma de Madrid, 3 Darwin Street, 28049, Madrid, Spain.
Francisco J IborraDepartment of Molecular and Cell Biology, Centro Nacional de Biotecnología (CNB-CSIC), Universidad Autonóma de Madrid, 3 Darwin Street, 28049, Madrid, Spain.ORCID http://orcid.org/0000-0002-0692-3696
Fernando AlmazanDepartment of Molecular and Cell Biology, Centro Nacional de Biotecnología (CNB-CSIC), Universidad Autonóma de Madrid, 3 Darwin Street, 28049, Madrid, Spain. falmazan@cnb.csic.es.
Luis Martínez-SobridoDepartment of Microbiology and Immunology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, New York, 14642, USA. luis_martinez@urmc.rochester.edu.
University of Rochester Medical Center · USCentro Nacional de Biotecnología · ES

Funding

Single-cycle infectious Zika viruses for the development of a live-attenuated vaccineR21AI130500 · NIAID · UNIVERSITY OF ROCHESTER · PI MARTINEZ-SOBRIDO, LUIS · 2017 to 2018
$380k
NIAID NIH HHS R21 AI130500
6 · The paper itself

Abstract

Zika virus (ZIKV) infection is currently one of the major concerns in human public health due to its association with neurological disorders. Intensive effort has been implemented for the treatment of ZIKV, however there are not currently approved vaccines or antivirals available to combat ZIKV infection. In this sense, the identification of virulence factors associated with changes in ZIKV virulence could help to develop safe and effective countermeasures to treat ZIKV or to prevent future outbreaks. Here, we have compared the virulence of two related ZIKV strains from the recent outbreak in Brazil (2015), Rio Grande do Norte Natal (RGN) and Paraiba. In spite of both viruses being identified in the same period of time and region, significant differences in virulence and replication were observed using a validated mouse model of ZIKV infection. While ZIKV-RGN has a 50% mouse lethal dose (MLD

Indexed as

Polymorphism, GeneticAmino Acid SubstitutionAnimalsApoptosisCell LineDisease Models, AnimalFemaleGenome, ViralGenomicsHost-Pathogen InteractionsImmunity, InnateMiceViral Nonstructural ProteinsVirulenceVirus ReplicationZika VirusViral Nonstructural Proteins

Identifiers

PMID31882898
PMCPMC6934710
OpenAlexW2998675608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.